|2.||Psoriasis (Pustulosis Palmaris et Plantaris)
|3.||Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
|4.||Sezary Syndrome (Sezary Erythroderma)
|5.||T-Cell Lymphoma (Lymphoma, T Cell)
|1.||Duvic, Madeleine: 39 articles (12/2014 - 01/2002)|
|2.||Kim, Youn H: 13 articles (11/2015 - 01/2003)|
|3.||Talpur, Rakhshandra: 12 articles (12/2014 - 01/2002)|
|4.||Kuzel, Timothy M: 10 articles (02/2014 - 10/2002)|
|5.||Querfeld, Christiane: 9 articles (10/2015 - 07/2004)|
|6.||Vonderheid, Eric C: 9 articles (01/2014 - 01/2002)|
|7.||Wood, Gary S: 8 articles (11/2015 - 02/2003)|
|8.||Willemze, Rein: 8 articles (01/2015 - 09/2002)|
|9.||Guitart, Joan: 8 articles (02/2014 - 10/2002)|
|10.||Assaf, Chalid: 8 articles (01/2013 - 07/2002)|
07/01/2003 - "The influence of psoralen + ultraviolet A treatment on the duration of remission and prognosis in mycosis fungoides."
11/01/2014 - "Treatment of stage Ia and Ib mycosis fungoides with psoralen UVA monotherapy: an observational study in tertiary hospitals in the Canary Islands."
08/01/2014 - "The purpose of this study was to compare the efficacy and safety of narrow-band UVB and psoralen plus ultraviolet A (PUVA) photochemoterapy in 24 patients with early-stage MF, and explore a new approach for the treatment of early mycosis fungoides. "
09/01/2014 - "Psoralen plus ultraviolet (UV) A (PUVA) radiation is the preferred treatment for folliculotropic mycosis fungoides (MF) and MF refractory to narrowband (NB) UVB radiation. "
09/01/2014 - "Role of bath psoralen plus ultraviolet A in early-stage mycosis fungoides."
|2.||Mechlorethamine (Nitrogen Mustard)FDA Link
01/01/2013 - "The use of a novel mechlorethamine, 0.02%, gel in the treatment of patients with mycosis fungoides is effective and safe. "
03/15/1999 - "To compare the efficacy of total skin electron beam therapy (TSEBT) with or without adjuvant topical nitrogen mustard (+/- HN2) with topical nitrogen mustard (HN2) alone as initial management of T2 and T3 mycosis fungoides (MF). "
01/01/1983 - "Remission of lesions in mycosis fungoides following topical application of nitrogen mustard. "
07/01/1980 - "In 10 patients with mycosis fungoides (MF) who were in clinical remission following local treatment with nitrogen mustard, cell-mediated immunity was investigated by means of tests for lymphocytes, forming rosettes in the peripheral blood, and the graft-vs-host reaction as well as intradermal skin tests. "
12/01/1968 - "In the present study, topically applied nitrogen mustard solution was used to control recurrences of mycosis fungoides following electron beam therapy in 11 patients. "
|3.||bexarotene (LGD1069)FDA Link
03/01/2003 - "Topical bexarotene is a novel synthetic rexinoid with few side-effects that has shown efficacy for treatment of mycosis fungoides skin lesions in recent Phase II-III clinical trials. "
01/01/2008 - "Safety and efficacy of low-dose bexarotene and PUVA in the treatment of patients with mycosis fungoides."
09/01/2012 - "EORTC 21011 (NCT 00056056) was a randomized phase III study comparing combined bexarotene (Targretin(®) ) and PUVA vs. PUVA alone in patients with stage IB and IIA mycosis fungoides (MF). "
01/01/2005 - "Because it was previously suggested that FMF may have a worse prognosis compared with classic mycosis fungoides, this impressive response to bexarotene is of great clinical interest and may spark new studies employing this novel retinoid for FMF treatment."
01/01/2015 - "The utility of bexarotene in mycosis fungoides and Sézary syndrome."
|4.||Interferon-alpha (Interferon Alfa)FDA Link
04/01/2007 - "Interferon-alpha is effective for CD4(+), CCR4(-) mycosis fungoides."
04/01/1987 - "This study was designed to evaluate the efficacy and tolerability of recombinant leukocyte interferon alfa-2a (Hoffmann-LaRoche) as single agent in patients with histologically confirmed Mycosis Fungoides. "
05/01/2007 - "Eight patients with 29 lesions of histologically verified 1st stage of Mycosis fungoides were successfully treated by electrochemotherapy with interferon-alpha. "
05/01/2007 - "Electrochemotherapy of Mycosis fungoides by interferon-alpha."
01/01/2007 - "Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?"
02/01/2005 - "Systemic interferon is effective in the treatment of mycosis fungoides (MF). "
03/01/2011 - " The combination of PUVA with variable doses of systemically administered interferon α2b (IFN-α2b) reduces the number of PUVA treatments and the dose of IFN-α2b required to produce remission in all mycosis fungoides (MF) stages. "
01/01/2014 - "A multisite, open-label, non-randomized, single-arm phase II study was conducted to evaluate the efficacy and safety profiles of interferon-γ in Japanese patients diagnosed with stage IA-IIIA mycosis fungoides (MF). "
01/01/2012 - "Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG) in patients with mycosis fungoides: an open-label trial."
04/01/2015 - "Results of the follow-up of patients with mycosis fungoides after interferon α2b treatment failure with the literature review and discussion."
|6.||Interferon Alfa-2a (Interferon Alfa 2a)FDA Link
10/01/1991 - "This study was designed to evaluate the therapeutic efficacy and toxicity of recombinant interferon alpha-2a (rIFN alfa-2a) given as initial systemic therapy in untreated mycosis fungoides and/or Sezary's syndrome patients, at a slowly escalating schedule up to the maximal tolerated dose. "
01/01/1995 - "To investigate the efficacy of combined topical therapy and systemic interferon alfa-2a in patients with mycosis fungoides (MF) and the Sézary syndrome (SS). "
01/01/1990 - "We previously demonstrated that recombinant interferon alfa-2a (IFN-alfa) in a dose of 50 X 10(6) U million units (MU)/m2 intramuscularly (IM) three times per week has efficacy against mycosis fungoides (MF) and the Sézary syndrome (SS). "
01/01/1990 - "Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome."
06/24/1989 - "Autoimmune haemolytic anaemia associated with interferon alfa-2a in a patient with mycosis fungoides."
|7.||alemtuzumab (Campath)FDA Link
01/01/2015 - "Alemtuzumab is a humanized mouse antibody targeting the CD52 cell surface, which has been effective in patients with advanced stage mycosis fungoides (MF) including erythrodermic MF and Sézary syndrome. "
06/01/2003 - "This phase 2 study evaluated the safety and efficacy of alemtuzumab in 22 patients with advanced mycosis fungoides/Sézary syndrome (MF/SS). "
08/01/2004 - "This study aims to describe the complications and outcomes of a subset of patients with mycosis fungoides/Sézary syndrome who were treated with alemtuzumab. "
09/01/2015 - "Alemtuzumab is a monoclonal antibody that has been used to treat refractory cases of Sézary syndrome (SS) and advanced mycosis fungoides. "
03/01/2014 - "Thirty-nine patients (median age 62 years, range 20-83) with Sézary syndrome (SS, n = 23) or advanced mycosis fungoides (MF, n = 16) received alemtuzumab 30 mg two to three times per week for a median duration of 12 weeks (range 1-35). "
|8.||Methotrexate (Mexate)FDA LinkGeneric
01/01/2003 - "Mycosis fungoides restricted to the palms: efficacy of methotrexate."
01/01/2013 - "A 77-year-old man with a 5-year history of mycosis fungoides (MF) who had received several lines of therapy, including intravenous courses of Methotrexate (MTX) for the past 2 years, went on to develop several ulcerated cutaneous nodules on the left leg. "
01/01/2013 - "EBV+ cutaneous B-cell lymphoproliferation of the leg in an elderly patient with mycosis fungoides and methotrexate treatment."
08/01/2011 - "To report a case of mycosis fungoides with subsequent intraocular involvement and good response to intravitreal methotrexate. "
12/01/2009 - "Folliculotropic mycosis fungoides in a psoriatic patient under methotrexate treatment."
|9.||Methoxsalen (Oxsoralen)FDA Link
11/01/2015 - "Photochemochemotherapy with 8-methoxypsoralen and UV-A light (PUVA) is a well-established treatment for mycosis fungoides (MF), although evidence for this therapy by means of prospective studies is scarce. "
01/01/2005 - "We retrospectively evaluated the outcomes of bath-water delivery of 8-MOP (1 mg l(-1)) in 16 patients with early stage mycosis fungoides. "
01/01/1979 - "Nine patients with stages 2 or 3 mycosis fungoides (MF) and one with Sézary's syndrome were treated with oral methoxsalen and long-wave ultraviolet light. "
11/12/1977 - "Six patients with mycosis fungoides were treated with methoxsalen and long-wave ultraviolet light. "
08/01/1976 - "The cutaneous manifestations of mycosis fungoides have been successfully treated in nine patients for 16 to 28 months with oral methoxsalen and subsequent irradiation with longwave ultraviolet light. "
|10.||imiquimod (Aldara)FDA LinkGeneric
01/01/2003 - "Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides."
01/01/2005 - "In the present study, we tested the efficacy of imiquimod in mycosis fungoides plaques."
01/01/2005 - "Efficacy of imiquimod in solitary plaques of mycosis fungoides."
11/01/2014 - "Histologic features mimicking mycosis fungoides induced by imiquimod, 5%: a potential pitfall for dermatopathologists."
03/01/2008 - "We assayed topical imiquimod in treating early stages of mycosis fungoides. "
|1.||Photochemotherapy (Photodynamic Therapy)
01/01/1987 - "[Photochemotherapy of patients with mycosis fungoides: a clinico-histomorphological study]."
01/01/1981 - "Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group."
01/01/1981 - "Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group."
07/01/1979 - "Photochemotherapy in mycosis fungoides--a study of fifty-six patients [proceedings]."
01/01/1979 - "Photochemotherapy for mycosis fungoides: a clinical and histological study."
|2.||Phototherapy (Light Therapy)
10/01/2012 - "UVA1 phototherapy was found to induce marked improvement in skin lesions of patients with stages IA and IB mycosis fungoides (MF). "
08/01/2005 - "Narrowband ultraviolet B (UVB) phototherapy for early-stage mycosis fungoides (MF) has been found to be beneficial in some reports. "
01/01/2005 - "No significant differences were found regarding the risk of developing mycosis fungoides or the tendency to remission in patients treated with or without phototherapy. "
11/01/2003 - "This preliminary study suggests that UVB phototherapy is an effective treatment for patients with early-stage mycosis fungoides."
05/01/2007 - "Phototherapy is effective for mycosis fungoides. "
|3.||Drug Therapy (Chemotherapy)
11/01/1979 - "Topical chemotherapy is effective in early stages of mycosis fungoides. "
12/28/1989 - "A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides."
01/01/1983 - "We have presented a study of two cases of Mycosis Fungoides with special emphasis on the staging of the disease as well as on the immunological findings and their modification with chemotherapy. "
01/01/2015 - "Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy."
12/01/2009 - "We describe an adult male patient clinically and pathologically diagnosed as mycosis fungoides and treated with chemotherapy after which complete involution of the lesions occurred. "
09/01/1998 - "Unilesional mycosis fungoides has a long natural history, is possibly the earliest manifestation of a malignant process, and local treatments, including local radiotherapy, result in long-term disease-free intervals and, possibly, cure. "
08/01/1989 - "Combined total body X-ray irradiation and total skin electron beam radiotherapy with an improved technique for mycosis fungoides."
01/01/2015 - "A clinical dilemma presents itself in a patient with lupus who presents with confluent skin lesions from mycosis fungoides requiring radiotherapy. "
08/01/2014 - "Radiotherapy (RT) is one of the treatments of choice as skin-directed therapy in Mycosis Fungoides (MF), both in first stages of the disease as total skin electron beam irradiation and in tumoural stage as localized treatment with conventional energies or electrons. "
08/01/2014 - "Localized conventional radiotherapy in the treatment of Mycosis Fungoides: our experience in 100 patients."
09/01/2000 - "PUVA therapy is highly effective in the treatment of mycosis fungoides confined to the skin, especially in the elderly where more aggressive therapy may not be tolerated."
01/01/2012 - "We report the case of a patient affected by mycosis fungoides and treated with PUVA therapy, with complete remission of the disease. "
04/01/2010 - "Bcl-2 expression in mycosis fungoides before and after PUVA therapy."
11/01/2009 - "PUVA therapy and narrowband UVB therapy (NBUVB) constitute a widely used first line therapy in mycosis fungoides (MF). "
11/01/2009 - "PUVA therapy and narrowband UVB therapy in Tunisian patients with mycosis fungoides."